RE:Acasti ScienceNeptune don't invest because they want to be below the 20% ownership and avoid the consolidation of all the losses since 2008. Nothing related to Acasti science. If Acasti science was so bad, we wouldn't be positive after 750 patients phase 1 & 2 . Market cap under $25M vs Amarin $1B . I think the visk vs potential upside is pretty good ... This is my evaluation. Future will tell :)